Results - Announcements
Lupin Ltd share price gained 0.15% to Rs 2015.0. The Company's net profit dropped 18.47% to Rs 1155.3 crore, while revenue from operations eased by 5.25% to Rs 7785.52 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.82 lakh crore, easing 5.14%. It has improved by 2.03% over last one week and crept higher by 1.77% in last one month while the market capitalization of Lupin Ltd has inched up 0.85% and 14.61% in the same period respectively.
Profit before tax (PBT) of Lupin Ltd stood at Rs 1579.6 crore in Q3 FY26, tumbling by 21.29% year-on-year, and nosediving by 21.70% quarter-on-quarter. EBITDA came in at Rs 1918 crore, dropping 14.82% YoY and plunging by 17.32% sequentially.
Total expenses slightly declined by 0.18% to Rs 6268.75 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 1310.74 crore, slightly declining by 0.07% YoY, while employee benefits expense was at Rs 1423.58 crore, inching up 2.93% YoY.
For the TTM ended FY26, revenue from operations jumped by 23.86% to Rs 27487.54 crore, while net profit soared by 61.98% to Rs 5355.47 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 529273% to Rs 8391.55 crore, and PBT witnessed a strong rise of 71.17% to Rs 6872.55 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 7334.5 crore in FY26, as against Rs 2999.94 crore in FY25.
Lupin Ltd ticked higher by 0.84% in last one year, significantly outperforming the benchmark BSE Sensex which has eased by 7.38% during the same period.